3M vs Colgate-Palmolive
3M generates revenues across industrial, safety, and health care segments with a patent portfolio that took decades to build, while Colgate-Palmolive wrings growth from toothpaste, pet nutrition, and oral health brands sold in nearly every country on earth. Both are mature consumer and industrial franchises where pricing power and cost discipline separate average from excellent. 3M vs Colgate-Palmolive puts two dividend stalwarts head to head on margin recovery, litigation exposure, and organic growth trajectory.
3M generates revenues across industrial, safety, and health care segments with a patent portfolio that took decades to build, while Colgate-Palmolive wrings growth from toothpaste, pet nutrition, and ...
Why It's Moving
3M Faces Mixed Analyst Signals as Recent Updates Hint at Modest Upside Amid Sector Headwinds.
- Wells Fargo raised its price target to $165 on April 22, signaling confidence in 3M's earnings trajectory after four straight quarters of beats.
- RBC Capital and Citigroup maintained ratings on April 22 and 13, respectively, with an average target implying over 6% upside from current levels around $146.
- Consensus tilts toward moderate buy with 9 buys among recent calls, driven by expected 6.3% EPS growth to $8.57 in fiscal 2026.
Colgate-Palmolive stock faces technical headwinds as analysts signal caution amid execution risks
- Technical analysis reveals bearish signals including negative MACD and Awesome Oscillator readings, with the stock trading within a falling trend and positioned for potential weakness over the coming weeks
- Analysts cite execution risks surrounding the company's 3-year strategic growth and productivity program, with average price targets implying modest downside of approximately 1.26% from current levels
- August 2026 forecasts project potential weakness with predicted returns of negative 14.27%, though April historically shows strong seasonal strength with a 78.57% probability of positive returns, creating near-term volatility
3M Faces Mixed Analyst Signals as Recent Updates Hint at Modest Upside Amid Sector Headwinds.
- Wells Fargo raised its price target to $165 on April 22, signaling confidence in 3M's earnings trajectory after four straight quarters of beats.
- RBC Capital and Citigroup maintained ratings on April 22 and 13, respectively, with an average target implying over 6% upside from current levels around $146.
- Consensus tilts toward moderate buy with 9 buys among recent calls, driven by expected 6.3% EPS growth to $8.57 in fiscal 2026.
Colgate-Palmolive stock faces technical headwinds as analysts signal caution amid execution risks
- Technical analysis reveals bearish signals including negative MACD and Awesome Oscillator readings, with the stock trading within a falling trend and positioned for potential weakness over the coming weeks
- Analysts cite execution risks surrounding the company's 3-year strategic growth and productivity program, with average price targets implying modest downside of approximately 1.26% from current levels
- August 2026 forecasts project potential weakness with predicted returns of negative 14.27%, though April historically shows strong seasonal strength with a 78.57% probability of positive returns, creating near-term volatility
Investment Analysis
3M
MMM
Pros
- 3M has raised its 2025 earnings outlook, reflecting improved profitability and successful execution of its turnaround strategy.
- The company has delivered strong organic sales growth and expanded operating margins, driven by cost controls and a shift towards higher-margin products.
- Recent settlements of long-standing legal issues have reduced uncertainty and cleared the path for future growth and investment.
Considerations
- Despite recent gains, 3M's valuation scores only moderately on undervaluation metrics, suggesting limited upside potential for new investors.
- The stock has experienced significant volatility, with technical forecasts indicating possible downward pressure in the near term.
- Ongoing restructuring and product mix changes carry execution risks that could affect future performance.
Pros
- Colgate-Palmolive maintains a strong global brand presence and consistent demand for its consumer products across multiple categories.
- The company operates with a stable balance sheet and a history of reliable dividend payments, appealing to income-focused investors.
- Colgate-Palmolive benefits from a diversified product portfolio, including oral care, personal care, and pet nutrition segments.
Considerations
- Revenue growth has been relatively slow, constrained by mature markets and limited pricing power in key regions.
- The company faces increasing competition from private labels and new entrants in the consumer goods sector.
- Exposure to foreign exchange fluctuations and input cost volatility can impact profitability.
3M (MMM) Next Earnings Date
3M's next earnings announcement is estimated to occur between July 17, 2026 and July 27, 2026, as the company has not yet announced a specific date. This report will cover the company's second quarter 2026 results. Based on historical patterns, investors should anticipate a conference call with executives to discuss financial performance and forward guidance around that timeframe.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to release its next earnings on May 1, 2026, before the market opens. This report will cover the Q1 2026 results, following the prior quarter's release on January 30, 2026. Investors should note the scheduled conference call at 8:30 AM ET on the same day.
3M (MMM) Next Earnings Date
3M's next earnings announcement is estimated to occur between July 17, 2026 and July 27, 2026, as the company has not yet announced a specific date. This report will cover the company's second quarter 2026 results. Based on historical patterns, investors should anticipate a conference call with executives to discuss financial performance and forward guidance around that timeframe.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to release its next earnings on May 1, 2026, before the market opens. This report will cover the Q1 2026 results, following the prior quarter's release on January 30, 2026. Investors should note the scheduled conference call at 8:30 AM ET on the same day.
Buy MMM or CL in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
